Company · CIK 0000881464
AMYLIN PHARMACEUTICALS INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001193125-12-352731 · 163.5 KBSEC(opens sec.gov)
- 4Insider trades0001264124-12-000189 · 19.9 KBSEC(opens sec.gov)
- 4Insider trades0001264124-12-000186 · 32.9 KBSEC(opens sec.gov)
- SC 13G/AAMYLIN PHARMACEUTICALS INC0000902219-12-000562 · 19.4 KBSEC(opens sec.gov)
- SC 13G/AAMYLIN PHARMACEUTICALS INC0000315066-12-003846 · 7.6 KBSEC(opens sec.gov)
- SC 13D/AAMYLIN PHARMACEUTICALS INC0000928464-12-000195 · 143.1 KBSEC(opens sec.gov)
- 10-QQuarterly update0000881464-12-000017 · 9.5 MBSEC(opens sec.gov)
- 4Insider trades0000881464-12-000009 · 5.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-12-292510 · 528.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-12-290439 · 49.2 KBSEC(opens sec.gov)
Insiders
- ADAMS ADRIANDirector
- ALTMAN STEVEN RDirector
- BARON ALAIN DSr VP Research
- BECK TERESADirector
- BEHRENS M KATHLEENDirector
- BLACK BEAR OFFSHORE MASTER FUND LP10% Owner
- BRADBURY DANIELPresident & Chief Executive Of, President & Chief Executive Of
- BROWN MARTIN RSr VP Human Resources and Corp
- BRYSON VAUGHN DDirector
- CLARK PAUL NDirector
Tickers
No tickers on record.
Addresses
business
9360 TOWNE CENTRE DR SUITE 110
SAN DIEGO, CA, 92121
mailing
9360 TOWNE CENTRE DR SUITE 110
SAN DIEGO, CA, 92121
Same industry